Cargando…

Serum fatty acid binding protein 5 (FABP5) as a potential biomarker of inflammation in psoriasis

Fatty acid binding protein 5 (FABP5) is elevated in psoriatic keratinocytes and could be involved in systemic metabolic disturbances in psoriasis. The aim of the study was to evaluate serum FABP5 in obese and non-obese psoriatic patients, to assess the relationship between FABP5 and the duration, se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kozłowska, Dorota, Myśliwiec, Hanna, Harasim-Symbor, Ewa, Milewska, Anna Justyna, Chabowski, Adrian, Flisiak, Iwona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260421/ https://www.ncbi.nlm.nih.gov/pubmed/34131888 http://dx.doi.org/10.1007/s11033-021-06461-3

Ejemplares similares

Serum fatty acid profile in psoriasis and its comorbidity
por: Myśliwiec, Hanna, et al.
Publicado: (2017)

Serum sphingolipid level in psoriatic patients with obesity
por: Kozłowska, Dorota, et al.
Publicado: (2019)

Lipid profile disturbances may predispose psoriatic patients to liver dysfunction
por: Kozłowska, Dorota, et al.
Publicado: (2021)

Abnormal serum fatty acid profile in psoriatic arthritis
por: Mysliwiec, Hanna, et al.
Publicado: (2019)

Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients
por: Myśliwiec, Hanna, et al.
Publicado: (2016)

The Role of Sphingolipids in the Pathogenesis of Psoriasis
por: Matwiejuk, Mateusz, et al.
Publicado: (2022)

Lack of pronounced changes in the expression of fatty acid handling proteins in adipose tissue and plasma of morbidly obese humans
por: Grzegorczyk, Ewa Anna, et al.
Publicado: (2018)

Effects of Hypolipidemic Drugs on Psoriasis
por: Matwiejuk, Mateusz, et al.
Publicado: (2023)

Arachidonic Acid as an Early Indicator of Inflammation during Non-Alcoholic Fatty Liver Disease Development
por: Sztolsztener, Klaudia, et al.
Publicado: (2020)

Crosstalk between Serum and Skin Sphingolipids in Psoriasis
por: Matwiejuk, Mateusz, et al.
Publicado: (2023)

Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol
por: Bielawiec, Patrycja, et al.
Publicado: (2020)

How do phytocannabinoids affect cardiovascular health? An update on the most common cardiovascular diseases
por: Dziemitko, Sylwia, et al.
Publicado: (2023)

Cannabidiol improves muscular lipid profile by affecting the expression of fatty acid transporters and inhibiting de novo lipogenesis
por: Bielawiec, Patrycja, et al.
Publicado: (2023)

How Hypertension Affects Heart Metabolism
por: Polak-Iwaniuk, Agnieszka, et al.
Publicado: (2019)

Time-Dependent Changes in Hepatic Sphingolipid Accumulation and PI3K/Akt/mTOR Signaling Pathway in a Rat Model of NAFLD
por: Sztolsztener, Klaudia, et al.
Publicado: (2021)

Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease
por: Wasilewska, Natalia, et al.
Publicado: (2018)

Serum Fatty Acid-Binding Protein 4 is Increased in Patients with Psoriasis
por: Baran, A., et al.
Publicado: (2016)

Fatty Acid-Binding Proteins in Psoriasis—A Review
por: Nowowiejska, Julia, et al.
Publicado: (2022)

Chronic Cannabidiol Administration Attenuates Skeletal Muscle De Novo Ceramide Synthesis Pathway and Related Metabolic Effects in a Rat Model of High-Fat Diet-Induced Obesity
por: Bielawiec, Patrycja, et al.
Publicado: (2020)

Attenuation of Oxidative Stress and Inflammatory Response by Chronic Cannabidiol Administration Is Associated with Improved n-6/n-3 PUFA Ratio in the White and Red Skeletal Muscle in a Rat Model of High-Fat Diet-Induced Obesity
por: Bielawiec, Patrycja, et al.
Publicado: (2021)

Distinct Effects of Cannabidiol on Sphingolipid Metabolism in Subcutaneous and Visceral Adipose Tissues Derived from High-Fat-Diet-Fed Male Wistar Rats
por: Berk, Klaudia, et al.
Publicado: (2022)

Beneficial Changes in Rat Vascular Endocannabinoid System in Primary Hypertension and under Treatment with Chronic Inhibition of Fatty Acid Amide Hydrolase by URB597
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2021)

Cannabidiol Downregulates Myocardial de Novo Ceramide Synthesis Pathway in a Rat Model of High-Fat Diet-Induced Obesity
por: Charytoniuk, Tomasz, et al.
Publicado: (2022)

How Does CBG Administration Affect Sphingolipid Deposition in the Liver of Insulin-Resistant Rats?
por: Bzdęga, Wiktor, et al.
Publicado: (2023)

Level of Fatty Acid Binding Protein 5 (FABP5) Is Increased in Sputum of Allergic Asthmatics and Links to Airway Remodeling and Inflammation
por: Suojalehto, Hille, et al.
Publicado: (2015)

Vitamin K2 as a New Modulator of the Ceramide De Novo Synthesis Pathway
por: Kołakowski, Adrian, et al.
Publicado: (2021)

High-Fat Feeding in Time-Dependent Manner Affects Metabolic Routes Leading to Nervonic Acid Synthesis in NAFLD
por: Konstantynowicz-Nowicka, Karolina, et al.
Publicado: (2019)

The Interplay between Bioactive Sphingolipids in the Psoriatic Skin and the Severity of the Disease
por: Matwiejuk, Mateusz, et al.
Publicado: (2023)

Fatty Acid-Binding Protein 7 (FABP-7), Glutamic Acid and Neurofilament Light Chain (NFL) as Potential Markers of Neurodegenerative Disorders in Psoriatic Patients—A Pilot Study
por: Nowowiejska, Julia, et al.
Publicado: (2022)

The Influence of Coumestrol on Sphingolipid Signaling Pathway and Insulin Resistance Development in Primary Rat Hepatocytes
por: Zywno, Hubert, et al.
Publicado: (2021)

Experimental Activation of Endocannabinoid System Reveals Antilipotoxic Effects on Cardiac Myocytes
por: Harasim-Symbor, Ewa, et al.
Publicado: (2020)

Delta-6 desaturase (Fads2) deficiency alters triacylglycerol/fatty acid cycling in murine white adipose tissue
por: Wang, Chenxuan, et al.
Publicado: (2023)

Cigarette smoke inhibits LPS-induced FABP5 expression by preventing c-Jun binding to the FABP5 promoter
por: Rao, Deviyani, et al.
Publicado: (2017)

Vasoprotective Endothelial Effects of Chronic Cannabidiol Treatment and Its Influence on the Endocannabinoid System in Rats with Primary and Secondary Hypertension
por: Baranowska-Kuczko, Marta, et al.
Publicado: (2021)

A Critical Role of Fatty Acid Binding Protein 4 and 5 (FABP4/5) in the Systemic Response to Fasting
por: Syamsunarno, Mas Rizky A. A., et al.
Publicado: (2013)

Fatty Acid Binding Protein 5 (FABP5) Promotes Aggressiveness of Gastric Cancer Through Modulation of Tumor Immunity
por: Qiu, Mei-qing, et al.
Publicado: (2023)

Effect of methotrexate treatment on the expression of epidermal-fatty acid-binding protein (E-FABP) and apolipoproteins in patients with psoriasis
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2020)

Liver fatty acid-binding protein might be a predictive marker of clinical response to systemic treatment in psoriasis
por: Baran, Anna, et al.
Publicado: (2019)

Epidermal Fatty Acid-Binding Protein 5 (FABP5) Involvement in Alpha-Synuclein-Induced Mitochondrial Injury under Oxidative Stress
por: Wang, Yifei, et al.
Publicado: (2021)

The covalent reactivity of functionalized 5-hydroxy-butyrolactams is the basis for targeting of fatty acid binding protein 5 (FABP5) by the neurotrophic agent MT-21
por: Svenningsen, Esben B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k5gn4nupha1okivif88s4kb3ll